Mold-contaminated antibiotic recalled nationwide: 5 things to know

AuroMedics Pharma issued a voluntary nationwide recall for one lot of its flexible bags containing the antibiotic linezolid for injection. The company issued the recall after the products were found to contain white particulate matter identified as mold, according to a recall announcement published by the Food and Drug Administration on Dec. 22.

Advertisement

Here are five things to know.

1. The product was distributed to wholesalers and hospitals around the country from May 15 through Aug. 14.

2. AuroMedics has notified customers of the recall via recall letters.

3. Use of the product should be immediately discontinued and could potentially result in fatal infections in many patients.

4. AuroMedics has not received any reports of adverse events attributable to the recalled antibiotic.

5. Linezolid injection is used to treat multiple infections caused by gram-negative bacteria, including vancomycin-resistant Enterococcus faecium, community-acquired pneumonia and diabetic foot infections.

More articles on supply chain: 
Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2B: 3 things to know 
Teen inspires Dignity Health CEO to cut plastic straw use across system’s 39 hospitals 
5 latest FDA approvals

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.